borderline significantP ‐value = 0.053
Serological evidence of prior infection with HSV‐1 was also associated with modestly increased odds of developing MS (OR: 1.54, 95% CI: 1.06–2.25, P ‐value = 0.025), while for the association with HSV‐2 was only borderline significant (OR: 1.54, 95% CI: 1.00–2.38, P ‐value = 0.053).